Estrone and 17beta-estradiol reverse breast cancer resistance protein-mediated multidrug resistance.
Article Details
- CitationCopy to clipboard
Imai Y, Tsukahara S, Ishikawa E, Tsuruo T, Sugimoto Y
Estrone and 17beta-estradiol reverse breast cancer resistance protein-mediated multidrug resistance.
Jpn J Cancer Res. 2002 Mar;93(3):231-5.
- PubMed ID
- 11927002 [ View in PubMed]
- Abstract
Breast cancer resistance protein (BCRP), an adenosine triphosphate-binding cassette transporter, confers resistance to a series of anticancer reagents, including mitoxantrone, SN-38 and topotecan. In the present study, we found that estrone and 17beta-estradiol potentiated the cytotoxicity of mitoxantrone, SN-38 and topotecan in BCRP-transduced K562 cells (K562 / BCRP). These estrogens showed only a marginal effect, or none, in parental K562 cells. Estrone and 17beta-estradiol increased the cellular accumulation of topotecan in K562 / BCRP cells, but not in K562 cells, suggesting that these estrogens inhibit the BCRP-mediated drug efflux and overcome drug resistance.
DrugBank Data that Cites this Article
- Drug Transporters
Drug Transporter Kind Organism Pharmacological Action Actions Estradiol ATP-binding cassette sub-family G member 2 Protein Humans UnknownInhibitorDetails Estradiol acetate ATP-binding cassette sub-family G member 2 Protein Humans UnknownInhibitorDetails Estradiol benzoate ATP-binding cassette sub-family G member 2 Protein Humans UnknownInhibitorDetails Estradiol cypionate ATP-binding cassette sub-family G member 2 Protein Humans UnknownInhibitorDetails Estradiol dienanthate ATP-binding cassette sub-family G member 2 Protein Humans UnknownInhibitorDetails Estradiol valerate ATP-binding cassette sub-family G member 2 Protein Humans UnknownInhibitorDetails Estrone ATP-binding cassette sub-family G member 2 Protein Humans UnknownInhibitorDetails